Teams from The Institute received $18.4 million in project funding
SOURCE: Research Institute of the McGill University Health Centre (The Institute) and CIHR
February 11, 2025
Researchers at the Research Institute of the McGill University Health Centre (The Institute) will embark on 17 new projects designed to accelerate discoveries of benefit to human health, thanks to the Canadian Institutes of Health Research (CIHR) Fall 2024 Project Grants Competition. The Institute teams received $18.4 million in project funding.
Across Canada, this competition approved 453 research grants for a total investment of approximately $411 million. In addition, 105 priority announcement grants were funded for a total amount of over $14 million and 16 supplemental prizes were awarded for a total of $400K.
The CIHR Project Grant program is designed to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, health care, health systems, and/or health outcomes.
”We take great pride in the accomplishments of The Institute’s grant recipients and their teams. Their innovative projects, supported through this competition, promise to significantly enhance Canadian healthcare across various critical domains," said Dr. Rhian Touyz, Executive Director and Chief Scientific Officer at The Institute. “These outcomes underscore the unwavering commitment and exceptional caliber of our research community."
Congratulations to The Institute’s grant recipients and their teams!
PROJECT GRANTS
- Matthew P. Cheng
A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP) - Ines Colmegna
Investigating the anti-fibrotic effects of human multipotent mesenchymal stromal cells - Stella S. Daskalopoulou
Early Prediction of preeclampsia using Urinary biomarkers anaLyseS in high-risk prEgnancies (PULSE-U) - Gustavo Duque
Investigating the Diagnostic and Therapeutic Role of the Kynurenine Pathway in Osteosarcopenia - Sabah N. A. Hussain
Regulation of skeletal muscle and peroxisomal homeostasis by Depp1 protein - Bertrand J. Jean-Claude
Engineering metabolically stable molecules toward tandem targeting of EGFR, its variant EGFRvIII and DNA for killing stem cells and preventing recurrence in the treatment of glioblastom multiforme (GBM) - Loydie A. Jerome-Majewska
Mouse Models of Spliceosomopathies: The Role of Snrpb in Axial Development - Wassim Kassouf
Unraveling immune-microbiome networks in radiation-based organ-preserving therapies for muscle-invasive bladder cancer - Todd C. Lee
An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform - Ivan V. Litvinov
Co-creating and implementing integrated dermatology care and augmenting skin research in Quebec northern Indigenous communities. - Madhukar Pai
Why are women at greater risk for multi-drug resistant tuberculosis? - Basil J. Petrof
The role of trained macrophages in dystrophic diaphragm pathology - Louise Pilote
Role of Sex and Gender on Hypertension-mediated Multi-organ Damage - Justin J. Sanders
AI-generated electronic health record summaries to promote high-quality communication and care in serious illness: a feasibility trial - Abhinav Sharma
Delivering Evidence-Based Care Using Artificial Intelligence to Patients with Diabetes and CardioVascular Comorbidities: From Proof of Concept to Multi-Centre Expansion (DECIDE-CV-2) - Rhian M. Touyz
Rho kinase as a novel therapeutic target in small vessel disease and vascular dementia - insights from a Notch3 disease - Pia Wintermark
Sildenafil to repair the injured brain of critically-ill neonates with hypoxic-ischemic encephalopathy
PRIORITY ANNOUNCEMENTS
- Ahmed, Sara
INtegrated Smart ImplemeNtation of Care (IN-SINC) in Rehabilitation - Claire Godard-Sebillotte
Améliorer l'équité en première ligne pour les personnes avec troubles neurocognitifs majeurs: Une étude à méthodes mixtes axée sur le patient - Wei-Hsiang Huang
Molecular pathogenesis of Smith-Magenis syndrome and developing therapy using hiPSC-derived neuronal models - Thomas Mavrakanas
Effect of Canagliflozin on Peritoneal Function and Fibrosis in Patients on Peritoneal Dialysis: a proof-of-concept randomized crossover clinical trial (CAN-PD trial). - Joanna Przybyl
Towards improving treatment outcomes in leiomyosarcoma through multi-omic liquid biopsy - Shaifali Sandal
Disaster risk reduction and management in kidney care to foster health system resilience - Giada Sebastiani
ELITE-2D: Enhancing Liver Health for People with Type 2 Diabetes through Patient-Centered Strategies
Learn more on the Canadian Institutes of Health Research website.
Related News
Spring 2024 CIHR competition results